Khiron Life Sciences Corp.
KHRNH.V
TSX
Weiss Ratings | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.09 | |||
Price History | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 0.00% | |||
2-Year Total Return | -60.00% | |||
3-Year Total Return | -79.49% | |||
5-Year Total Return | -93.33% | |||
52-Week High % Change | -11.11% | |||
52-Week Low % Change | 0.00% | |||
Price | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.05 | |||
52-Week Low Price | $0.04 | |||
52-Week Low Price (Date) | Mar 06, 2025 | |||
52-Week High Price (Date) | Mar 06, 2025 | |||
Valuation | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 232.00 | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.13 | |||
Earnings Per Share Growth | 54.00% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.68 | |||
Price/Book (Q) | 0.44 | |||
Enterprise Value/Revenue (TTM) | 0.62 | |||
Price | $0.04 | |||
Enterprise Value/EBITDA (TTM) | -0.63 | |||
Enterprise Value/EBIT | -0.58 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 214.53M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 647 556-5750 | |||
Address | -- | |||
Website | khiron.ca | |||
Country | Canada | |||
Year Founded | 2012 | |||
Profitability | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -108.04% | |||
Profit Margin | -191.21% | |||
Management Effectiveness | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -21.21% | |||
Return on Equity | -- | |||
Income Statement | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 12.65M | |||
Total Revenue (TTM) | 12.65M | |||
Revenue Per Share | $0.06 | |||
Gross Profit (TTM) | 5.22M | |||
EBITDA (TTM) | -12.62M | |||
EBIT (TTM) | -13.67M | |||
Net Income (TTM) | -24.19M | |||
Net Income Avl. to Common (TTM) | -24.19M | |||
Total Revenue Growth (Q YOY) | -7.14% | |||
Earnings Growth (Q YOY) | -3.45% | |||
EPS Diluted (TTM) | -0.13 | |||
EPS Diluted Growth (Q YOY) | 3.77% | |||
Balance Sheet | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.41M | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | 13.35M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 19.74M | |||
Current Ratio (Q) | 2.022 | |||
Book Value Per Share (Q) | $0.09 | |||
Total Assets (Q) | 28.01M | |||
Total Current Liabilities (Q) | 6.60M | |||
Total Debt (Q) | 1.87M | |||
Total Liabilities (Q) | 8.27M | |||
Total Common Equity (Q) | 19.74M | |||
Cash Flow | KHRNH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -2.45M | |||
Cash from Financing (TTM) | 3.71M | |||
Net Change in Cash (TTM) | -10.59M | |||
Levered Free Cash Flow (TTM) | -7.00M | |||
Cash from Operations (TTM) | -11.74M | |||